IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

YVONNE D HALL

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1922029164
CMS profile
178441
Location
RIO RANCHO, NM

General Payments · PY2018–2024

$11,900.88

  • Reported across 670 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,207.16

71 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry NM All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,207.16 71

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $370.01 23
ITI, Inc. $221.19 13
Otsuka America Pharmaceutical, Inc. $160.61 10
Janssen Pharmaceuticals, Inc $155.17 5
ABBVIE INC. $152.16 13
Axsome Therapeutics, Inc. $94.27 4
Neurocrine BioSciences, Inc. $32.29 2
Takeda Pharmaceuticals U.S.A., Inc. $21.46 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,044.95 116
PY2019 $2,298.06 113
PY2020 $1,855.63 106
PY2021 $1,785.84 107
PY2022 $1,784.60 102
PY2023 $924.64 55
PY2024 $1,207.16 71

Payment records · PY2024 (71)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $20.02 01/04/2024 Food and Beverage Undisputed 01/23/2026 1103866969 CMS
ABBVIE INC. $18.52 03/22/2024 Food and Beverage Undisputed 01/23/2026 1103866971 CMS
ABBVIE INC. $11.24 03/26/2024 Food and Beverage Undisputed 01/23/2026 1103866973 CMS
ABBVIE INC. $7.04 05/07/2024 Food and Beverage Undisputed 01/23/2026 1103866975 CMS
ABBVIE INC. $5.04 06/04/2024 Food and Beverage Undisputed 01/23/2026 1103866977 CMS
ABBVIE INC. $23.71 06/26/2024 Food and Beverage Undisputed 01/23/2026 1103866979 CMS
ABBVIE INC. $10.40 07/03/2024 Food and Beverage Undisputed 01/23/2026 1103866981 CMS
ABBVIE INC. $7.84 08/27/2024 Food and Beverage Undisputed 01/23/2026 1103866983 CMS
ABBVIE INC. $8.42 09/25/2024 Food and Beverage Undisputed 01/23/2026 1103866985 CMS
ABBVIE INC. $5.76 10/15/2024 Food and Beverage Undisputed 01/23/2026 1103866987 CMS
ABBVIE INC. $6.24 11/18/2024 Food and Beverage Undisputed 01/23/2026 1103866989 CMS
ABBVIE INC. $19.87 11/19/2024 Food and Beverage Undisputed 01/23/2026 1103866991 CMS
ABBVIE INC. $8.06 12/11/2024 Food and Beverage Undisputed 01/23/2026 1103866993 CMS
Axsome Therapeutics, Inc. $26.95 02/14/2024 Food and Beverage Undisputed 01/23/2026 1148329225 CMS
Axsome Therapeutics, Inc. $27.45 03/12/2024 Food and Beverage Undisputed 01/23/2026 1148329227 CMS
Axsome Therapeutics, Inc. $17.76 09/23/2024 Food and Beverage Undisputed 01/23/2026 1148329229 CMS
Axsome Therapeutics, Inc. $22.11 12/18/2024 Food and Beverage Undisputed 01/23/2026 1148329231 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $7.66 01/08/2024 Food and Beverage Undisputed 01/23/2026 1143238076 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9.26 01/22/2024 Food and Beverage Undisputed 01/23/2026 1143238079 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.45 02/05/2024 Food and Beverage Undisputed 01/23/2026 1143238083 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.44 02/27/2024 Food and Beverage Undisputed 01/23/2026 1143238087 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.18 03/13/2024 Food and Beverage Undisputed 01/23/2026 1143238090 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.61 03/27/2024 Food and Beverage Undisputed 01/23/2026 1143238094 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.14 05/06/2024 Food and Beverage Undisputed 01/23/2026 1143238098 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.37 06/04/2024 Food and Beverage Undisputed 01/23/2026 1143238101 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.91 07/09/2024 Food and Beverage Undisputed 01/23/2026 1143238105 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.74 08/12/2024 Food and Beverage Undisputed 01/23/2026 1143238108 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.01 08/27/2024 Food and Beverage Undisputed 01/23/2026 1143238112 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.64 10/07/2024 Food and Beverage Undisputed 01/23/2026 1143238116 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9.78 10/22/2024 Food and Beverage Undisputed 01/23/2026 1143238119 CMS
Janssen Pharmaceuticals, Inc $13.38 01/30/2024 Food and Beverage Undisputed 01/23/2026 1078098864 CMS
Janssen Pharmaceuticals, Inc $7.71 02/20/2024 Food and Beverage Undisputed 01/23/2026 1078098882 CMS
Janssen Pharmaceuticals, Inc $14.06 03/19/2024 Food and Beverage Undisputed 01/23/2026 1078098862 CMS
Janssen Pharmaceuticals, Inc $115.09 04/04/2024 Food and Beverage Undisputed 01/23/2026 1078098858 CMS
Janssen Pharmaceuticals, Inc $4.93 07/23/2024 Food and Beverage Undisputed 01/23/2026 1078098868 CMS
Neurocrine Biosciences, Inc. $14.26 06/17/2024 Food and Beverage Undisputed 01/23/2026 1150877010 CMS
Neurocrine Biosciences, Inc. $18.03 10/16/2024 Food and Beverage Undisputed 01/23/2026 1150865434 CMS
Otsuka America Pharmaceutical, Inc. $29.13 02/21/2024 Food and Beverage Undisputed 01/23/2026 1118904029 CMS
Otsuka America Pharmaceutical, Inc. $19.34 02/26/2024 Food and Beverage Undisputed 01/23/2026 1118904031 CMS
Otsuka America Pharmaceutical, Inc. $8.89 04/02/2024 Food and Beverage Undisputed 01/23/2026 1118904033 CMS
Otsuka America Pharmaceutical, Inc. $23.35 04/09/2024 Food and Beverage Undisputed 01/23/2026 1118904035 CMS
Otsuka America Pharmaceutical, Inc. $20.36 05/22/2024 Food and Beverage Undisputed 01/23/2026 1118904037 CMS
Otsuka America Pharmaceutical, Inc. $0.46 05/22/2024 Food and Beverage Undisputed 01/23/2026 1118904039 CMS
Otsuka America Pharmaceutical, Inc. $22.18 07/08/2024 Food and Beverage Undisputed 01/23/2026 1118904041 CMS
Otsuka America Pharmaceutical, Inc. $18.52 07/23/2024 Food and Beverage Undisputed 01/23/2026 1118904043 CMS
Otsuka America Pharmaceutical, Inc. $15.06 08/13/2024 Food and Beverage Undisputed 01/23/2026 1118904045 CMS
Otsuka America Pharmaceutical, Inc. $3.32 09/10/2024 Food and Beverage Undisputed 01/23/2026 1118904047 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.46 04/03/2024 Food and Beverage Undisputed 01/23/2026 1137568628 CMS
Teva Pharmaceuticals USA, Inc. $16.43 01/09/2024 Food and Beverage Undisputed 01/23/2026 1151607042 CMS
Teva Pharmaceuticals USA, Inc. $16.61 02/13/2024 Food and Beverage Undisputed 01/23/2026 1151607052 CMS
Teva Pharmaceuticals USA, Inc. $11.07 03/13/2024 Food and Beverage Undisputed 01/23/2026 1151607058 CMS
Teva Pharmaceuticals USA, Inc. $21.76 04/10/2024 Food and Beverage Undisputed 01/23/2026 1151607192 CMS
Teva Pharmaceuticals USA, Inc. $25.23 04/16/2024 Food and Beverage Undisputed 01/23/2026 1151607194 CMS
Teva Pharmaceuticals USA, Inc. $9.84 04/30/2024 Food and Beverage Undisputed 01/23/2026 1151607204 CMS
Teva Pharmaceuticals USA, Inc. $9.19 05/06/2024 Food and Beverage Undisputed 01/23/2026 1151607206 CMS
Teva Pharmaceuticals USA, Inc. $23.42 05/14/2024 Food and Beverage Undisputed 01/23/2026 1151607208 CMS
Teva Pharmaceuticals USA, Inc. $7.83 05/29/2024 Food and Beverage Undisputed 01/23/2026 1151607224 CMS
Teva Pharmaceuticals USA, Inc. $13.78 06/03/2024 Food and Beverage Undisputed 01/23/2026 1151607226 CMS
Teva Pharmaceuticals USA, Inc. $14.62 06/10/2024 Food and Beverage Undisputed 01/23/2026 1151607228 CMS
Teva Pharmaceuticals USA, Inc. $10.70 06/12/2024 Food and Beverage Undisputed 01/23/2026 1151607230 CMS
Teva Pharmaceuticals USA, Inc. $2.55 07/01/2024 Food and Beverage Undisputed 01/23/2026 1151607244 CMS
Teva Pharmaceuticals USA, Inc. $5.92 07/09/2024 Food and Beverage Undisputed 01/23/2026 1151607246 CMS
Teva Pharmaceuticals USA, Inc. $8.72 07/22/2024 Food and Beverage Undisputed 01/23/2026 1151607254 CMS
Teva Pharmaceuticals USA, Inc. $76.48 07/23/2024 Food and Beverage Undisputed 01/23/2026 1151607248 CMS
Teva Pharmaceuticals USA, Inc. $23.67 08/14/2024 Food and Beverage Undisputed 01/23/2026 1151607256 CMS
Teva Pharmaceuticals USA, Inc. $8.97 08/26/2024 Food and Beverage Undisputed 01/23/2026 1151607258 CMS
Teva Pharmaceuticals USA, Inc. $7.14 09/09/2024 Food and Beverage Undisputed 01/23/2026 1151607260 CMS
Teva Pharmaceuticals USA, Inc. $16.59 09/11/2024 Food and Beverage Undisputed 01/23/2026 1151607262 CMS
Teva Pharmaceuticals USA, Inc. $20.99 09/16/2024 Food and Beverage Undisputed 01/23/2026 1151607264 CMS
Teva Pharmaceuticals USA, Inc. $4.02 10/07/2024 Food and Beverage Undisputed 01/23/2026 1151607268 CMS
Teva Pharmaceuticals USA, Inc. $14.48 11/06/2024 Food and Beverage Undisputed 01/23/2026 1151607270 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.